Results 221 to 230 of about 1,911,748 (355)

Application of biomarkers in the diagnosis of kidney disease. [PDF]

Front Med (Lausanne)
Lu Z, Ni W, Wu Y, Zhai B, Zhao Q, Zheng T, Liu Q, Ding D.   +7 more
europepmc   +1 more source

Polycystic Disease of the Liver, Pancreas and Kidneys [PDF]

, 1939
Manville W. Norton
openalex   +1 more source

RBC Membrane‐Camouflaged Nanosystem‐Mediated Synergistic Drug Combination for Enhanced Anti‐Tumor Therapy

Advanced Healthcare Materials, EarlyView.
An RBC membrane camouflaged, cell‐penetrating peptides R8‐based drug delivery system is constructed to achieve a synergistic combination of natural compounds triptolide (TP) and celastrol (Cel), inducing tumor cell apoptosis, reducing tumor metastasis invasion and triggering autophagy disorder in breast cancer and liver cancer.
Qian Cheng, Xuemei Zhong, Lu Deng, Xinling He, Miaoxizi Luo, Ruibing Wang, Jinming Zhang   +6 more
wiley   +1 more source

Microphysiological Systems for Comorbidity Studies: Chronic Kidney Disease and Osteoarthritis

Advanced Healthcare Materials, EarlyView.
This review highlights the potential of organ‐on‐a‐chip systems for studying comorbidities, using chronic kidney disease (CKD) and osteoarthritis (OA) as examples. It summarizes recent advances in kidney‐on‐a‐chip and joint‐on‐a‐chip models and discusses their current and potential application in investigating CKD, OA, and CKD‐OA comorbidity, aiming to
Mingying Han, Weiping Lin, Yuanxiong Cao, Patricia Murray, Bettina Wilm, Stephen J McWilliam, Jude Curran, Ruoxiao Xie   +7 more
wiley   +1 more source

Prevalence of chronic kidney disease in France - The constances cohort. [PDF]

BMC Nephrol
Blacher J, Kab S, Cheddani L, Halimi JM, Stengel B, De Pinho NA, Goldberg M, Zins M, Olié V.   +8 more
europepmc   +1 more source

OBSERVATIONS ON THE FUNCTIONAL HOMOGENEITY OF THE NEPHRON POPULATION IN THE CHRONICALLY DISEASED KIDNEY OF THE DOG* [PDF]

, 1960
Neal S. Bricker, Tadeusz Orłowski, S. Wesley Kime, Peter A. F. Morrin   +3 more
openalex   +1 more source

Nanobody‐Decorated Lipid Nanoparticles for Enhanced mRNA Delivery to Tumors In Vivo

Advanced Healthcare Materials, EarlyView.
This study presents a targeted mRNA‐LNP platform engineered with anti‐PSMA nanobodies for prostate cancer therapy. Using different in vivo models, the authors demonstrate selective uptake and mRNA delivery in PSMA+ cancer cells. However, while targeting is enhanced, mRNA delivery efficacy is limited by tissue penetration, tumor necrosis, and immune ...
Pol Escudé Martinez de Castilla, Vincenzo Verdi, Willemijn de Voogt, Mariona Estapé Sentí, Arnold C. Koekman, Julian Rietveld, Sven van Kempen, Qiangbing Yang, Juliette van Merris, Guido Jenster, Martin E. van Royen, Marcel H. Fens, Sander A. A. Kooijmans, Wytske M. van Weerden, Guillaume van Niel, Pieter Vader, Raymond M. Schiffelers   +16 more
wiley   +1 more source

Cardiovascular Risk and Its Presentation in Chronic Kidney Disease. [PDF]

J Clin Med
Schunk SJ, Zimmermann P.
europepmc   +1 more source

Case of Diseased Kidney and Rectum [PDF]

John B. Bachelder
openalex   +1 more source

Light Chain Distribution in Immune Deposits on Glomeruli of Kidneys in Human Renal Disease* [PDF]

, 1967
Roger Herdman, Richard Hong, Alfred F. Michael, Robert A. Good   +3 more
openalex   +1 more source